ANDA 88285, held by Morton Grove. Trimeprazine Tartrate.
As of Nov 15, 2026, ANDA 88285 (Trimeprazine Tartrate), held by Morton Grove, was not approved, with 0 approved supplements and 0 published complete response letters.
| Product | Active ingredient | Marketing |
|---|---|---|
| Trimeprazine TartrateEQ 2.5MG BASE/5ML ยท syrup;oral | Trimeprazine Tartrate | Discontinued |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters
